Science

AstraZeneca, developer of Sputnik V, explores the possibility of combining Covid-19 vaccines

[ad_1] British pharmaceutical giant AstraZeneca unveiled plans to collaborate with Russia’s Sputnik V developer, Moscow-based Gamaleya Research Institute of Epidemiology and Microbiology, and explore whether its two coronavirus vaccines could be successfully combined. “Today we announce a program of clinical trials to evaluate the safety and immunogenicity of the AZD1222 …

Read More »